← SynDRA
SULFINPYRAZONE
SynDRA canonical compound SYN0002106 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ABCC1 |
|---|
| Mechanism of action | Uricosuric blocker |
|---|
| Indication | gout |
|---|
| Disease area | rheumatology |
|---|
All known targets
- SLC22A12
- ABCC1
- FPR1
- NAPRT
Mechanisms of action (all sources)
- Uricosuric blocker
- SLC22A12 INHIBITOR
- Solute carrier family 22 member 12 inhibitor
- FPR1 ANTAGONIST
- ABCC1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- MC4R
- MAOA
- MAPK1
- MAPK14
- MAPK3
- MAPT
- MC3R
- MC5R
- ABCB11
- MDH1
- MLNR
- MMP1
- MMP9
- NPY1R
- NPY2R
- LMNA
- ABCB1
- KDM4E
- KCNH2
- KAT2A
- IDH1
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HSD17B10
- HRH2
- HRH1
- HPGD
- HMGCR
- LCK
- NR3C1
- OPRD1
- SLC6A2
- VDR
- UGT1A9
- UGT1A6
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP2C9
- CP3A4
- CP3A7
- ITA4
- MDR1
- PHGDH
- PRMT1
Drug classes
- Antirheumatic Agents
- Gout Suppressants
- Uricosuric Agents
ATC classes
- M04A · ANTIGOUT PREPARATIONS
Cross-references
Synonyms
- ANTURANE
- diphenylpyrazone
- sulfinpyrazon
- sulfoxyphenylpyrazolidine
- sulphinpyrazone
- sulfoxyphenylpyrazolidin
- Sulfinpirazona
- NSC-75925
- Anturan
- Anturane
- Anturanil
- Anturano
- Anturen
- Anturidin
- Diphenylpyrazone
- Enturan
- Enturen
- Novopyrazone
- Sulfinpyrazine
- Sulfinpyrazon
- Sulfinpyrazonum
- Sulfoxyphenylpyrazolidin
- Sulfoxyphenylpyrazolidine
- Sulphinpyrazone
- Apo-Sulfinpyrazone
- Apotex Brand of Sulfinpyrazone
- Novartis Brand of Sulfinpyrazone
- Nu-Pharm Brand of Sulfinpyrazone
- Nu-Sulfinpyrazone
- G 28315
- Anturane (TN)
- G 28,315
- Sulfinpirazona [INN-Spanish]
- Sulfinpyrazone (SPZ)
- Sulfinpyrazonum [INN-Latin]
- USAF GE-13
- Sulfinpyrazone [USAN:INN:JAN]
Look up SULFINPYRAZONE in the interactive SynDRA portal →